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objective: The hormonal-metabolic milieu in women with polycystic ovary syndrome (PCOS) contributes to cardiovascular risk clustering. We 
performed a meta-analysis to systematically review the effect of PCOS on the cardiovascular system.
methods: We searched PUBMED for studies comparing echocardiographic parameters or presence of coronary calcium (CAC) in women with PCOS 
and age- and BMI- matched controls. The pooled standardized mean differences (SMD) were fitted to random effect models to calculate the overall 
effect size estimates.
results: Thirteen studies totaling 660 PCOS patients were eligible. PCOS is associated with moderate increase in left ventricular mass (5 studies; 
SMD = 0.60, 95%CI: 0.38 - 0.81; p < 0.00), small increase in left atrial diameter (5 studies; SMD = 0.32, 95%CI: 0.12 - 0.53; p < 0.00), moderate 
decrease in peak early diastolic filling velocity (4 studies; SMD = -0.37, 95%CI: -0.60 - -0.14; p < 0.00), and small decrease in E/A (6 studies; 
SMD= -0.29, 95%CI: -0.48 - -0.10; p < 0.00). Ejection fraction and deceleration time differences did not reach significance. Women with PCOS have 
a tendency for positive CAC (4 studies; OR = 1.48, 95%CI: 0.91 - 2.41; p = 0.12).
conclusion: Compared with matched controls, women with PCOS have higher left ventricle mass and left atria size, and abnormal mitral flow 
parameters. Some of these changes are present in women with PCOS in their third decade of life, findings which may be harbingers of clinically 
significant heart disease later in life.
